Multivariate analyses demonstrated that LLGL2low/SLC7A5low was an independent favorable prognostic factor for DFS as well as lymph node negativity and ERα positivity in all analyzed breast cancer patients (Supplementary Table S7). The gene discussed is ESR1; the disease is breast cancer.